$43.15
1.333.18%
At close: -
$41.82
-1.33-3.08%
After Hours: Apr 30, 4:01 PM EDT
Comments
Loading...
Monopar Therapeutics Insider Trading Activity | NASDAQ:MNPR | Benzinga
Track the latest Monopar Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Monopar Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Monopar Therapeutics Inc Insiders Doing?
At Monopar Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 33.33K shares worth $1.17M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On April 4, 2025, Tactic Pharma LLC, Chandler Robinson, Michael Brown, Thomas OHalloran V, Paul Andrew Mazar, the company's CHIEF EXECUTIVE OFFICER sold 33.33K shares for $35 each.
Ownership Statistics for Monopar Therapeutics Inc
Shares Outstanding
6.103M
Insider Shares Owned
537.018K
Insider Percentage Owned
8.80%
Institutional Shares Held
74.317K
Institutional Percentage Held
1.20%
| Apr 04, 2025 | Tactic Pharma LLCChandler RobinsonMichael BrownThomas OHalloran VPaul Andrew Mazar | CHIEF EXECUTIVE OFFICER | -33.33K | $35.00 | -$1.17M | SELL | -3.90% | 822.25K | Apr 02 | View |
| Oct 30, 2024 | Karthik Radhakrishnan | CHIEF FINANCIAL OFFICER | 1.55K | $16.25 | $25.19K | BUY | ∞ | 1.55K | Oct 28 | View |
| Jun 21, 2024 | Andrew Cittadine | CHIEF OPERATING OFFICER | 32.51K | $0.79 | $25.57K | BUY | 21.16% | 186.13K | Jun 18 - Jun 20 | View |
| Jun 17, 2024 | Andrew Cittadine | CHIEF OPERATING OFFICER | 36.00K | $0.91 | $32.89K | BUY | 30.61% | 153.62K | Jun 13 - Jun 17 | View |
| Jun 05, 2024 | Andrew Cittadine | CHIEF OPERATING OFFICER | 24.00K | $0.77 | $18.48K | BUY | 25.63% | 117.62K | Jun 03 - Jun 04 | View |
| May 31, 2024 | Andrew Cittadine | CHIEF OPERATING OFFICER | 36.00K | $0.64 | $23.05K | BUY | 62.47% | 93.62K | May 29 - May 31 | View |
| Nov 16, 2022 | Andrew Cittadine | CHIEF OPERATING OFFICER | 16.05K | $3.09 | $49.66K | BUY | 196.13% | 24.24K | Nov 14 - Nov 15 | View |
| Feb 16, 2021 | Tactic Pharma LLCPaul Andrew MazarChandler RobinsonThomas OHalloran VMichael Brown | CHIEF SCIENTIFIC OFFICER, CHIEF EXECUTIVE OFFICER | -125.00K | $14.64 | -$1.83M | SELL | -2.84% | 4.28M | Feb 11 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
